Patents by Inventor Soren Brogger Christensen

Soren Brogger Christensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of glycosides of mono- and diacyglycerol as anti-inflammatory agents
    Patent number: 7084122
    Abstract: Glycosides of diacylglycerol, e.g. 3-?-D-galactopyranosyloxy-2-(octadeca-9Z,12Z,15Z-trienoyloxy)propanyl octadeca-9Z,12Z,15Z-trienoate (GOPO), which was isolated from extracts of rose-hips by activity guided fractionation, can be used as an oral anti-inflammatory agent for the treatment of inflammatory diseases such as arthritis and osteoarthrosis.
    Type: Grant
    Filed: November 21, 2002
    Date of Patent: August 1, 2006
    Inventors: Erik Larsen, Arsalan Kharazmi, Søren Brøgger Christensen, Lars Porskjær Christensen, Kirsten Brandt
  • Bis-aromatic a,&bgr;-unsaturated ketones
    Patent number: 6603046
    Abstract: The invention is drawn to novel bis-aromatic a,&bgr;-unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria.
    Type: Grant
    Filed: May 27, 1998
    Date of Patent: August 5, 2003
    Assignee: Lica Pharmaceuticals A/S
    Inventors: Arsalan Kharazmi, Søren Brøgger Christensen, Chen Ming, Thor Grundtvig Theander
  • Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents
    Publication number: 20030139350
    Abstract: Glycosides of diacylglycerol, e.g. 3-&bgr;-D-galactopyranosyloxy-2-(octadeca-9Z,12Z,15Z-trienoyloxy)propanyl octadeca-9Z,12Z,15Z-trienoate (GOPO), which was isolated from extracts of rose-hips by activity guided fractionation, can be used as an oral anti-inflammatory agent for the treatment of inflammatory diseases such as arthritis and osteoarthrosis.
    Type: Application
    Filed: November 21, 2002
    Publication date: July 24, 2003
    Inventors: Erik Larsen, Arsalan Kharazmi, Soren Brogger Christensen, Lars Porskjaer Christensen, Kirsten Brandt
  • Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones
    Publication number: 20030065039
    Abstract: The invention relates to the use of 1,3-bis-aromatic-prop-2-en-1-ones (chalcones), 1,3-bis-aromatic-propan-1-ones (dihydrochalcones), and 1,3-bis-aromatic-prop-2-yn-1-ones for the preparation of pharmaceutical compositions for the treatment or prophylaxis of a number of serious diseases including i) conditions relating to harmful effects of inflammatory cytokines, ii) conditions involving infection by Helicobacter species, iii) conditions involving infection by viruses, iv) neoplastic disorders, and v) conditions caused by microorganisms or parasites. The invention also relates to novel chalcones and dihydrochalcones (especially alkoxy substituted variants) having advantageous substitution patterns with respect to their effect as drug substances, and to methods of preparing them, as well as to pharmaceutical compositions comprising the novel chalcones.
    Type: Application
    Filed: January 31, 2002
    Publication date: April 3, 2003
    Applicant: Statens Serum Institute
    Inventors: Arsalan Kharazmi, Soren Brogger Christensen, Simon Feldbaek Nielsen